GORE VIABIL Biliary Endoprosthesis VSWVN1008Recalls & reported problems
W. L. Gore & Associates, Inc. · VIABIL SHORT WIRE BILIARY ENDO 10mmX8cmX200cm 8.5Fr · Class 2 · Implant
All models of GORE VIABIL Biliary Endoprosthesis (11)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00733132638871), received between Feb 24, 2022 and Dec 14, 2023 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Material Split, Cut or Torn” (1 report).
1 FDA recall record name this device's identifier, 1 still open.
3 other recalls cover devices cleared under the same FDA submission (K170740); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Recalls naming this device
- Jan 19, 2024Class IIOpen, Classified
Devices without transmural drainage holes may be mislabeled as devices with transmural drainage holes, or vice versa. Potential health impact includes extending procedure time, unplanned device removal, secondary procedure, cholangitis, cholecystitis, and/or pain. The GORE VIABIL Short Wire Biliary Endoprosthesis is a flexible, self-expanding endoprosthesis designed to maintain luminal patency of the common bile duct which may be obstructed. The endoprosthesis is radially compressed and secured onto the distal end of a catheter-based delivery system for deployment. The catheter provides a means for accessing and implanting the GORE VIABIL Short Wire Biliary Endoprosthesis at the target site in the biliary tract.
Z-1179-2024 · Root cause: Packaging process control · Recall details · FDA record ↗
Most reported problems
Device problems
- Material Split, Cut or Torn1
- Unraveled Material1
Patient problems
- Obstruction/Occlusion1
- Stenosis1
- Swelling/ Edema1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 14, 2023Material Split, Cut or Torn; Material Split, Cut or Torn
IT WAS REPORTED TO GORE BY CONMED (CEN-65010) THAT DURING A REPEAT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE, DUE TO INCREASED LFTS USING THE GORE® VIABIL® SHORT WIRE BILIARY ENDOPROSTHESIS, REPORTEDLY, THE STENT WAS OCCLUDED. THE PLAN WAS TO PERFORM A STENT EXCHANGE, IT WAS REPORTED THAT PARTS OF THE STENT DISINTEGRATED DURING REMOVAL, AND SMALL PIECES WERE REMOVED. THERE WAS REPORTEDLY A 30 MINUTE DELAY OF PROCEDURE. ANOTHER GORE® VIABIL® SHORT WIRE BILIARY ENDOPROSTHESIS WAS USED TO COMPLETE THE PROCEDURE. THE PATIENT STATUS IS UNKNOWN AT THIS TIME. THE DEVICE IS AVAILABLE FOR RETURN.
Patient problems: Obstruction/Occlusion
MAUDE report 18332050 ↗MalfunctionFeb 24, 2022Unraveled Material; Unraveled Material
IT WAS REPORTED TO GORE BY CONMED ((B)(4)) THAT DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE USING THE GORE® VIABIL® BILIARY ENDOPROSTHESIS, DR.(B)(6) HAD PLACED A VIABIL®. HE PROCEEDED TO REMOVE THE VIABIL® (OFF LABEL) AND IT BEGAN TO UNRAVEL. IT WAS LODGED INTO THE BILE DUCT. THE SALES REP SPOKE WITH (B)(6) WHO IS THE LEAD ADMIN AT U OF C AND ALSO SPOKE WITH DR. (B)(6) ON THE PHONE OFFERING HELP. A MONTH LATER DR. (B)(6) WAS ABLE TO REMOVE THE VIABIL® FROM THE PATIENT WITH NO OTHER ISSUES. THERE WAS NO IMPACT TO THE PATIENT. A HISTOLOGY KIT HAS BEEN ORDERED FOR THE RETURN OF THE EXPLANTED DEVICE.
Patient problems: Stenosis; Swelling/ Edema
MAUDE report 13591856 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K170740. One submission often covers many models, so check the product and lot details in each record.
- Z-0158-2027 · Sep 3, 2026 · Open, ClassifiedGeneric Name: GORE VIABIL Short Wire Biliary Endoprosthesis; Model/Catalog Number: VSWVH0808 and VSWVN1006 Product Description: The GORE VIABIL Short Wire Biliary Endoprosthesis
- Z-2915-2026 · May 22, 2026 · Open, ClassifiedGORE VIABIL Short Wire Biliary Endoprosthesis, Model No. VSWVN1006. Flexible, self-expanding endoprosthesis designed to maintain luminal patency of the common bile duct which may b
- Z-2914-2026 · May 22, 2026 · Open, ClassifiedGORE VIABIL Short Wire Biliary Endoprosthesis, Model No. VSWVN1010. Flexible, self-expanding endoprosthesis designed to maintain luminal patency of the common bile duct which may b
Other Catheter, Biliary, Diagnostic devices
- Hurricane™ RX M00545900Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC2 recalls1 death705 reports
- MUSTANG™ H74939171060470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC384 reports
- CRE™ PRO M00558710Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC1 recall284 reports
- Hurricane™ RX M00545920Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC2 recalls211 reports
- MUSTANG™ H74939171070470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC265 reports
- MUSTANG™ H74939171050470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC212 reports
- Hurricane™ RX M00545940Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC2 recalls109 reports
- MUSTANG™ H74939171100470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC203 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page